About the EGA - Structure
Structure of EGA
The EGA's main decision-making body is the Board. This is elected once a year at the Annual General Meeting and consists of representatives of member companies and associations. The management of the EGA is carried out by an Executive Committee.
Technical review of EU and international proposals and the formulation
of detailed EGA policies are carried out by six committees. These are: the
Regulatory and Scientific Affairs Committee, the Health Economics Committee,
the Legal Affairs (IP) Committee, the CEE & Accession Committee, the Biotechnology
& Biosimilars Committee, and the National Associations Committee.
Director General
Executive Committee — 2012-2013
- Mrs Edda Eggertsdottir - Chairman/President
- Mr Emile Loof - Secretary (1st Vice President)
- Mr Didier Barret - Treasurer (2nd Vice President)
- Dr György Thaler - Chair, Legal Affairs Committee
- Mr Frank Bongers - Chair, Health Economics Committee
- Mr Joris Van Assche - Chair, National Associations Committee
- TBC - Chair, Regulatory & Scientific Affairs Committee
- Mr Nick Haggar - Executive Officer
- Dr Dr Michel Mikhail - Executive Officer
- Mr Luc Slegers - Executive Officer
- Mr Warwick Smith - Executive Officer
- Mr José Luis Stampa - Executive Officer
EGA Membership & Membership Requirements
|
